ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Clark Wins Sheen award; Research Training Cuts Prompt PhD Holders To Apply Medical Schools

July 12, 1974

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010